STAT3 is a known MS risk gene (26), and somatic gain-of-function mutations in this gene in CD8+ T cells in large granular lymphocytic leukemia are associated with an increased incidence of RA (13). This evidence concerns the gene STAT3 and T-cell large granular lymphocyte leukemia.